Blood cancers often begin with genetic mutations in the stem cells.

血癌往往是由干细胞中的基因突变开始的。

She conducts research on blood cancers.

她对血癌进行研究。

This phenomenon can help eradicate stubborn blood cancers.

这个现象能帮助患者清除顽固的血癌细胞。

The two other treatments are specially designed treatments for forms of blood cancer.

另外的两种疗法是针对白血病的基因疗法。

He has also donated blood cells to people with blood cancer.

他也捐献了血细胞给患有血癌的病人。

He had blood cancer which experts say put him at a greater risk.

专家说，他患有血癌，这使他面临更大的风险。

Unfortunately, also like her mother, she developed blood cancer because of her exposure to radiation.

不幸的是，和她的母亲一样，她也因为遭受辐射得了血癌。

And a year ago I was diagnosed with Hodgkin Lymphoma which is a type of blood cancer.

一年前，我被诊断患有霍奇金淋巴瘤，这是一种血癌。

Fifty percent to 80 percent of patients with other blood cancers also saw a reduction in symptoms.

50%到80%患有其它类型白血病的患者的症状也有所减轻。

He added that other cell therapies for some blood cancers have worked very well, even taking diseases that are uncurable and curing them.

他补充说，治疗某些血癌的其他细胞疗法也有非常好的效果，甚至" 是接受无法治愈的疾病并治疗它们" 。

The same 11 genetic markers they are looking at are the same used to fight blood cancers.

他们正在研究的 11 种相同的遗传标记与用于对抗血癌的相同。

It’s a blood cancer that occurs when a person’s bone marrow starts churning out immature and abnormal white blood cells.

这是一种血癌，当一个人的骨髓开始大量产生不成熟和异常的白细胞时就会发生。

One of these eases the symptoms of multiple sclerosis; the other one cures a type of blood cancer that we call T-cell lymphoma.

其中之一可以缓解多发性硬化症的症状；另一种可以治愈一种我们称之为 T 细胞淋巴瘤的血癌。

And she was this incredible person who was only 29 when she received a terminal diagnosis with a very rare kind of blood cancer.

她是一位了不起的人，年仅 29 岁就被诊断出患有一种非常罕见的血癌。

Even in people with acute myeloid leukemia— an aggressive blood cancer — chemotherapy puts an estimated 60% of patients under 60 into remission following their first phase of treatment.

即使在患有急性髓性白血病（侵袭性血液癌）的人中，60％的年龄在60岁以下的患者接收他们的第一阶段化疗后症状缓解。

Likewise, a mutation in bone-marrow cells can cause the overproduction of red blood cells, like in the case of a different kind of blood cancer, called polycythemia vera.

同样，骨髓细胞的突变会导致红细胞过度生成， 就像另一种称为真性红细胞增多症的血癌一样。

So for patients with advanced blood cancers like leukemia and lymphoma, the best chance for a cure is often an allogeneic bone marrow transplant, which replaces the patient's bone marrow with a donor's.

因此，对于重症血癌，例如白血病或淋巴癌的患者来说，最有可能治愈的手段通常是异体骨髓移植，能将患者的骨髓替换成捐献者的骨髓。

Prolacta Bioscience, a biotech firm in California, is conducting a clinical trial of one sub-species called B. infantis, combined with HMOs, in adults undergoing bone-marrow transplants for blood cancer (a procedure that wipes out the immune system).

加州的一家生物技术公司 Prolacta Bioscience 正在对一种名为 B. infantis 的亚种与 HMO 结合进行临床试验，试验对象为接受骨髓移植治疗血癌（一种消灭免疫系统的程序）的成年人。